logo

For the Inventor, By the Inventor

Nagano, Japan

Nobuyuki Tanaka

USPTO Granted Patents = 16

 


Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 27(Granted Patents)


Location History:

  • Nagano, JP (1993 - 2008)
  • Toyoshina-machi, JP (2003 - 2008)
  • Azumino, JP (2011 - 2012)

Company Filing History:

goldMedal16 out of 176 
 
Kissei Pharmaceutical Co., Ltd.
 patents

Years Active: 1993-2012

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 8258162 - Catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition (2012-09-04),
2. 7923462 - Catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition (2011-04-12),
3. 7402692 - Intermediates in producing phenoxyacetic acid derivatives and method of using the same (2008-07-22),
4. 7396954 - Intermediates in producing phenoxyacetic acid preventives and method of using the same (2008-07-08),
5. 7393968 - Intermediates in producing phenoxyacetic acid derivatives and method of using the same (2008-07-01),
6. 7329771 - Intermediates in producing phenoxyacetic acid derivatives and method of using the same (2008-02-12),
7. 6790865 - 2-methylpropionic acid derivatives and pharmaceutical compositions comprising the same (2004-09-14),
8. 6696489 - 2-Methylpropionic acid derivatives and medicinal compositions containing the same (2004-02-24),
9. 6538152 - Phenoxyacetic acid derivatives and medicinal compositions containing the same (2003-03-25),
10. 6399660 - Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis (2002-06-04),
11. 6376707 - Crystal polymorphism of aminoethylphenoxyacetic acid derivative (2002-04-23),
12. 6353025 - Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same (2002-03-05),
13. 6136852 - 3,4-disubstituted phenylethanolaminotetralincarboxylic acid derivatives (2000-10-24),
14. 6133266 - 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives (2000-10-17),
15. 6046192 - Phenylethanolaminotetralincarboxamide derivatives (2000-04-04),

Title: Nobuyuki Tanaka: Innovator in Pharmaceutical Chemistry

Introduction

Nobuyuki Tanaka is a prominent inventor based in Nagano, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of catechol derivatives. With a total of 16 patents to his name, Tanaka's work has had a substantial impact on the industry.

Latest Patents

Tanaka's latest patents include innovative compounds represented by general formula (I) that exhibit potent COMT inhibitory activities. These compounds are designed for use in pharmaceutical compositions, providing new avenues for treatment options. His inventions focus on the pharmaceutical composition containing catechol derivatives and their various applications, showcasing his expertise in this specialized area.

Career Highlights

Tanaka is currently associated with Kissei Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating effective pharmaceutical solutions that address various medical needs. His dedication to innovation in the pharmaceutical sector is evident through his numerous patents and ongoing research.

Collaborations

Throughout his career, Tanaka has collaborated with notable colleagues, including Tetsuro Tamai and Harunobu Mukaiyama. These partnerships have fostered a collaborative environment that enhances the quality and scope of their research endeavors.

Conclusion

Nobuyuki Tanaka's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence the development of new therapeutic options, making a lasting impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…